Rabbit Polyclonal Antibody to FKBP9 (N-term)
货号：
P30388
别名：
Peptidyl-prolyl cis-trans isomerase FKBP9, PPIase FKBP9, 63 kDa FK506-binding protein, 63 kDa FKBP, FKBP-63, FK506-binding protein 9, FKBP-9, Rotamase, FKBP9, FKBP60, FKBP63
应用：
WB,IHC,FCM
反应种属：
Human, Mouse
抗体类型：
Primary antibody
Swissprot：
O95302
规格：
目录价
在线咨询
Description |
|---|
FKBP9 is a PPIase which accelerate the folding of proteins during protein synthesis. |
Specification |
|
|---|---|
| Aliases | Peptidyl-prolyl cis-trans isomerase FKBP9, PPIase FKBP9, 63 kDa FK506-binding protein, 63 kDa FKBP, FKBP-63, FK506-binding protein 9, FKBP-9, Rotamase, FKBP9, FKBP60, FKBP63 |
| Entrez GeneID | 11328 |
| Swissprot | O95302 |
| WB Predicted band size | 63.1kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse |
| Immunogen | This FKBP9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 51-80 amino acids from the N-terminal region of human FKBP9. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,1%BSA and 50% glycerol.prepared by Saturated Ammonium Sulfate (SAS) . |
Application |
|
|---|---|
| WB | 1/1000 |
| IHC | 1/100-1/500 |
| FCM | 1/10-1/50 |
Product Image
-
Western blot analysis of FKBP9 antibody (N-term) (Cat.# P30388) in mouse kidney tissue lysates (35ug/lane). FKBP9 (arrow) was detected using the purified Pab.
-
FKBP9 Antibody (N-term) (Cat. #P30388) flow cytometric analysis of NCI-H460 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
-
FKBP9 Antibody (N-term) (Cat.# P30388) IHC analysis in formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the FKBP9 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.
鄂公网安备42018502007531号
